コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ds to enhanced expression of hepatic IGFBP1 (insulin-like growth factor-binding protein-1).
2 ith available measurements of baseline serum insulin-like growth factor binding protein-1.
3 0-fold increase in the expression of hepatic insulin-like growth factor binding protein-1.
4 arboxykinase, tyrosine aminotransferase, and insulin-like growth factor-binding protein 1.
5 s PRL, dermal fibroblasts did not co-express insulin-like growth factor-binding protein-1.
6 factor-I, insulin-like growth factor-II, and insulin-like growth factor binding proteins 1, 2, and 3
8 imately 70% decrease in the plasma levels of insulin-like growth factor binding protein-1, a marker o
9 serum insulin-like growth factor-I (IGF-I), insulin-like growth factor binding protein-1 and -3 (IGF
10 ing globulin, estrone, estradiol, C-peptide, insulin-like growth factor-binding proteins 1 and 2, adi
11 ctor receptor-binding protein 10 (GRB10) and insulin-like growth factor-binding proteins 1 and 3 (IGF
12 ttern of the thyroglobulin type 1A domain of insulin-like growth factor-binding proteins 1 and 6.
14 Insulin-like growth factor binding protein 1 concentrati
15 nts DAF-16 binding to its target site in the insulin-like growth factor binding protein-1 gene, the i
16 phosphatase [G6Phase], and secreted factors (insulin-like growth factor binding protein 1 [GFBP-1].
17 iferator-activated receptor alpha), IGFBP-1 (insulin-like growth factor binding protein 1), HIF3alpha
20 sulin negatively regulates expression of the insulin-like growth factor binding protein 1 (IGFBP-1) g
21 ntrast, phage-derived peptide antagonists of insulin-like growth factor binding protein 1 (IGFBP-1) h
24 genes and proteins in regenerating liver is insulin-like growth factor binding protein 1 (IGFBP-1),
25 c-containing superoxide dismutase 1 (SOD-1), insulin-like growth factor binding protein 1 (IGFBP-1),
26 a 20-fold increase in hepatic expression of insulin-like growth factor binding protein 1 (IGFBP-1),
27 on of multiple genes in the liver, including insulin-like growth factor binding protein-1 (IGFBP-1) a
29 sistance, accompanied by decreased levels of insulin-like growth factor binding protein-1 (IGFBP-1) m
31 patic gene expression using the model of the insulin-like growth factor binding protein-1 (IGFBP-1) p
33 cts with an insulin response sequence in the insulin-like growth factor-binding protein-1 (IGFBP-1) g
34 hosphoenolpyruvate carboxykinase (PEPCK) and insulin-like growth factor-binding protein-1 (IGFBP-1) g
35 binds to the insulin response element of the insulin-like growth factor-binding protein-1 (IGFBP-1) p
37 ession profiling revealed elevated levels of insulin-like growth factor binding protein 1 (IGFBP1) tr
38 (HGF), insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 1 (IGFBP1), m
39 esponse elements located in the promoters of insulin-like growth factor-binding protein 1 (IGFBP1) an
40 anges in microglial secretome and identified insulin-like growth factor-binding protein 1 (IGFBP1) as
42 on protein to activate transcription via the insulin-like growth factor binding protein-1-insulin res
43 with acute pulmonary embolism had the lowest insulin-like growth factor binding protein-1 level (5 2-
48 roteinase inhibitor and His(140)-Val(141) in insulin-like growth factor-binding protein-1, probably r
49 the insulin-responsive sequence (IRS) in the insulin-like growth factor-binding protein 1 promoter an
50 able to bind to its cognate sites within the insulin-like growth factor-binding protein 1 promoter on
51 articles and chromatin arrays containing the insulin-like growth factor-binding protein 1 promoter.
52 pG2 hepatoma cells show that FKHR stimulates insulin-like growth factor-binding protein-1 promoter ac
54 ver-operating-characteristic curve for serum insulin-like growth factor binding protein-1 was 0.98 0.
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。